Ecolab Beats Q2 Estimates, Lifts 2026 EPS Outlook on Strong Pricing
ECL is trading near its 52-week low of $243.15 (13% above the low).
Summary
Ecolab delivered a clean beat-and-raise quarter. Q2 sales of $4.42B edged past the $4.39B consensus, and adjusted EPS of $2.09 topped the $2.08 estimate. The company raised its full-year 2026 adjusted EPS outlook to $8.05–$8.25, implying 7–10% growth, and guided Q3 to $2.13–$2.23. Pricing gains, including an energy surcharge, and accelerating growth in Food & Beverage, Institutional, and Life Sciences drove the outperformance. This follows the early close of the $4.75B CoolIT Systems acquisition and a $5B debt raise, with the raised guidance giving the first clear read on the combined entity's earnings power. Organic sales growth is expected to accelerate to 6–7% in the second half, signaling demand momentum. The stock trades at 31x forward earnings, with a median analyst target of $325.
At the time of this announcement, ECL was trading at $275.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $76.4B. The 52-week trading range was $243.15 to $309.27. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.